PTC Therapeutics (PTCT) return on equity (ROE)

Return on equity · fiscal 2021
-36432.6%

PTC Therapeutics (PTCT) earned a return on equity of -36432.6% in fiscal 2021 (the year ended December 31, 2021). That is 36341.7 percentage points lower than the -90.9% of fiscal 2020. Figures as of 17 Nov 2026, 21:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2021
-36432.6%
Change on fiscal 2020
−36341.7 pts
Highest on record
-31.4%fiscal 2014
Lowest on record
-36432.6%fiscal 2021
Fiscal years on record
92013–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

PTC Therapeutics return on equity (ROE), in more detail

Across the 9 fiscal years on record (2013–2021), the highest was -31.4% in fiscal 2014 and the lowest -36432.6% in fiscal 2021. The fiscal 2021 figure is no higher than in any of the 8 earlier fiscal years on record, whose median is -46.4%.

History · 9 fiscal years

Return on equity by fiscal year

PTC Therapeutics return on equity (ROE), year by year

PTC Therapeutics (PTCT) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2021-36432.6% 36341.7 pts down
2020-90.9% 48.6 pts down
2019-42.3% 5.8 pts down
2018-36.5% 14.0 pts up
2017-50.5% 68.3 pts up
2016-118.8% 43.4 pts down
2015-75.4% 44.0 pts down
2014-31.4% 6.4 pts up
2013-37.8%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of PTC Therapeutics and comparable companies
CompanyReturn on equityFiscal year
BillionToOne BLLN1.6%2025
Hims & Hers Health HIMS23.7%2025
PTC Therapeutics PTCT-36432.6%2021
Haemonetics HAE12.2%2026
Erasca ERAS-38.3%2025
Concentra Group Holdings Parent CON42.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTCT

PTC Therapeutics, figure by figure

PTC Therapeutics (PTCT) overview: price, valuation and scorecardAll health care companies by market value

PTC Therapeutics return on equity (ROE): questions and answers

What is PTC Therapeutics's return on equity?

PTC Therapeutics (PTCT) earned a return on equity of -36432.6% in fiscal 2021 (the year ended December 31, 2021). That is 36341.7 percentage points lower than the -90.9% of fiscal 2020.

Is PTC Therapeutics's return on equity high or low compared with its own history?

The fiscal 2021 figure is no higher than in any of the 8 earlier fiscal years on record, whose median is -46.4%.

What are the highest and lowest return on equity figures on record for PTC Therapeutics?

Across the 9 fiscal years on record (2013–2021), the highest was -31.4% in fiscal 2014 and the lowest -36432.6% in fiscal 2021.

How is PTC Therapeutics's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PTC Therapeutics (PTCT) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/PTCT/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.